Adult Restoration of Shank3 Expression Rescues Selective Autistic-Like Phenotypes

Because autism spectrum disorders are neurodevelopmental disorders and patients typically display symptoms before the age of three, one of the key questions in autism research is whether the pathology is reversible in adults. Here we investigate the developmental requirement of Shank3 in mice, a prominent monogenic autism gene that is estimated to contribute to approximately 1% of all autism spectrum disorder cases. SHANK3 is a postsynaptic scaffold protein that regulates synaptic development, function and plasticity by orchestrating the assembly of postsynaptic density macromolecular signalling complex. Disruptions of the Shank3 gene in mouse models have resulted in synaptic defects and autistic-like behaviours including anxiety, social interaction deficits, and repetitive behaviour. We generated a novel Shank3 conditional knock-in mouse model, and show that re-expression of the Shank3 gene in adult mice led to improvements in synaptic protein composition, spine density and neural function in the striatum. We also provide behavioural evidence that certain behavioural abnormalities including social interaction deficit and repetitive grooming behaviour could be rescued, while anxiety and motor coordination deficit could not be recovered in adulthood. Together, these results reveal the profound effect of post-developmental activation of Shank3 expression on neural function, and demonstrate a certain degree of continued plasticity in the adult diseased brain.

[1]  C. D. De Zeeuw,et al.  Motor Learning and the Cerebellum. , 2015, Cold Spring Harbor perspectives in biology.

[2]  T. Bourgeron,et al.  Cntnap4/Caspr4 Differentially Contributes to GABAergic and Dopaminergic Synaptic Transmission , 2014, Nature.

[3]  Y. Takai,et al.  SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density. , 1997, The Journal of biological chemistry.

[4]  A. Bird,et al.  Reversal of Neurological Defects in a Mouse Model of Rett Syndrome , 2007, Science.

[5]  René Hen,et al.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult , 2002, Nature.

[6]  M. Poirier,et al.  The genotoxicity of tamoxifen: extent and consequences, Kona, Hawaii, January 23, 2003. , 2003, Mutagenesis.

[7]  T. Boeckers,et al.  Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family. , 1999, Biochemical and biophysical research communications.

[8]  Gavin Rumbaugh,et al.  Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses , 2012, Cell.

[9]  A. Beaudet,et al.  Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. , 2011, Human molecular genetics.

[10]  Christian R Marshall,et al.  Contribution of SHANK3 mutations to autism spectrum disorder. , 2007, American journal of human genetics.

[11]  Caiying Guo,et al.  A cre recombinase transgene with mosaic, widespread tamoxifen‐inducible action , 2002, Genesis.

[12]  Thomas Bourgeron,et al.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.

[13]  H. Faras,et al.  Autism spectrum disorders , 2010, Annals of Saudi medicine.

[14]  Patrick E. Rothwell,et al.  Autism-Associated Neuroligin-3 Mutations Commonly Impair Striatal Circuits to Boost Repetitive Behaviors , 2014, Cell.

[15]  James Y. Zhang,et al.  Reduced Excitatory Neurotransmission and Mild Autism-Relevant Phenotypes in Adolescent Shank3 Null Mutant Mice , 2012, The Journal of Neuroscience.

[16]  G. Feng,et al.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction , 2011, Nature.

[17]  C J Marshall,et al.  A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. , 1991, The EMBO journal.

[18]  Elodie Ey,et al.  Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments , 2014, PLoS genetics.

[19]  M. Sheng,et al.  The Shank family of scaffold proteins. , 2000, Journal of cell science.

[20]  P. Chambon,et al.  A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse , 2003, Nature Biotechnology.

[21]  S. Dudek,et al.  Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice , 2007, Nature.

[22]  Michael E. Greenberg,et al.  Activity-dependent neuronal signalling and autism spectrum disorder , 2013, Nature.

[23]  Mark J. Harris,et al.  Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication , 2010, Molecular autism.

[24]  Laurent Mottron,et al.  Novel de novo SHANK3 mutation in autistic patients , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  C. I. Zeeuw,et al.  Motor Learning and the Cerebellum , 2015 .

[26]  A. Breman,et al.  SHANK3 overexpression causes manic-like behavior with unique pharmacogenetic properties , 2013, Nature.

[27]  M. Sheng,et al.  GKAP, a Novel Synaptic Protein That Interacts with the Guanylate Kinase-like Domain of the PSD-95/SAP90 Family of Channel Clustering Molecules , 1997, The Journal of cell biology.

[28]  M. State,et al.  The genetics of autism: key issues, recent findings, and clinical implications. , 2010, The Psychiatric clinics of North America.